Investors Set Their Sights On Horizon Pharma
Executive Summary
Horizon Pharma has emerged out of two transformative deals as a high-growth specialty pharma with four commercially available drugs. Now it is on track to achieve profitability in 2014, and investors are perking up to hear more about the company’s acquisitive strategy, which includes more aggressive dealmaking.